维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Furlanut M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Antimicrobial therapy in critically ill patients : a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability显示文摘	Pea F Viale P Furlanut M	2005	Clin Pharmacokinet2005，44，10：	1
2	Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 显示文摘	PEA F VIALE P FURLANUT M	2005	Clin Pharmacokinet2005，44，10：	1
3	Antimierobial agents in elective surgery : prophylaxis or 'early therapy'? 显示文摘	Pea F Viale P Furlanut M	2003	J Chemother2003，15，1：	1
4	Levofloxacin PK/PD- from sequential therapy model to high dosage for critical patients显示文摘	Pea F Furlanut M	2004	J Chemother2004，16，2：	1
5	A simple method to monitor plasma con- centrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients 显示文摘	Franceschi L Furlanut M	2005	Phannacol Res2005，51，4：	1
6	Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible or ahered disposition and pharmacokinetic variability 显示文摘	Pea F Viale P Furlanut M	2005	Clin Pharmacokinet2005，44，10：	1
7	A simple method to mon- itor plas- ma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients 显示文摘	Franceschi L Furlanut M	2005	Pharmacological Research2005，51，2：	1
8	Pharmacokinetic aspects of treating infections in the intensive care unit:focus on drug interactions显示文摘	Furlanut M	2001	Clin Pharmacokinet2001，40，11：	1
9	Pharrnacokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections显示文摘	Furlanut M Brollo L Lugatti E	2003	JAntimicrob Chemother2003，51，1：	1
10	Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis显示文摘	Pea F Furlanut M Cojutti P	2010	Antimicrob Agents Chemother2010，54，11：	1
11	Prospectivelyvalidated dosing no- mograms for maximizing the pharmacodynamies ofvancomycin ad- ministered by continuous infusion in critically ill patients 显示文摘	Pea F Furlanut M Negri C	2009	Anti- microb Agents Chemother2009，53，：	1
12	Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 显示文摘	Viale P Furlanut M Scudeller L	2009	Int J Antimicrob Agents2009，33，4：	1
13	Treatment of pyogenic(non - tuberculous ) spondylodiscitis with tailored high -doselevofloxacin plus rifampicin 显示文摘	Viale P Furlanut M Scudeller L	2009	Int J Antimicrob Agents2009，33，4：	1
14	Therapeutic drug monitoring of linezolid:a retrospective monocentric analysis显示文摘	Pea F Furlanut M Cojutti P		0，，11：	1
15	Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients显示文摘	Pea F Furlanut M	2004	J Chemother2004，16，2：	1
16	Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation显示文摘	Furlanut M de Manzoni G Pasini F		0，，04：	1
17	Hydrogen bonding as a possible interaction for the chiral separation of DL-dopa and DL-3-O-methyl-dopa in a chiral teicoplanin column显示文摘	Wu G Furlanut M	1999	Il Farmaco1999，54，3：	1
18	Pharmacokinetic aspects of levo-floxacin 500mg once daily during sequential intravenous/oral thera-py in patients with lower respiratory tract infections显示文摘	Furlanut M’Brollo L’Lugatti E	2003	J AntimicrobChemother2003，51，1：	1
19	Therapeutic drug mon- itoring of linezolid: a retrospective monocentric analysis 显示文摘	Pea F Furlanut M Cojutti P	2010	Antimicrob Agents Chemother2010，54，11：	1
20	A simple method to monitor plasma concentrations of oxcarbazepine,carbamazepine,their main metabolites and lamotrigine in epileptic patients显示文摘	Franceschi L Furlanut M	2005	Pharmacol Res2005，51，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示